Ballentine Partners, LLC Boston Scientific Corp Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 29,388 shares of BSX stock, worth $2.63 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

29,388

Previous 31,840 7.7%

Holding current value

$2.63 Million

Previous $2.45 Million 0.45%

% of portfolio

0.04%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$72.96 - $84.0 $178,897 - $205,968	-2,452 Reduced 7.7%	29,388 $2.46 Million
Q2 2024 Aug 06, 2024	BUY	$67.33 - $77.71 $321,770 - $371,376	4,779 Added 17.66%	31,840 $2.45 Million
Q1 2024 Apr 11, 2024	BUY	$57.6 - $68.62 $114,796 - $136,759	1,993 Added 7.95%	27,061 $1.85 Million
Q4 2023 Jan 23, 2024	BUY	$48.64 - $57.81 $51,509 - $61,220	1,059 Added 4.41%	25,068 $1.45 Million
Q3 2023 Oct 19, 2023	BUY	$50.19 - $54.68 $6,976 - $7,600	139 Added 0.58%	24,009 $1.27 Million
Q2 2023 Jul 26, 2023	BUY	$49.72 - $54.64 $38,284 - $42,072	770 Added 3.33%	23,870 $1.29 Million
Q1 2023 Apr 27, 2023	BUY	$45.09 - $50.03 $209,758 - $232,739	4,652 Added 25.22%	23,100 $1.16 Million
Q4 2022 Jan 27, 2023	BUY	$39.56 - $47.22 $399,556 - $476,922	10,100 Added 120.99%	18,448 $0
Q3 2022 Oct 26, 2022	BUY	$36.71 - $109.66 $85,791 - $256,275	2,337 Added 38.88%	8,348 $323,000
Q2 2022 Aug 09, 2022	BUY	$35.24 - $47.1 $3,770 - $5,039	107 Added 1.81%	6,011 $224,000
Q1 2022 May 05, 2022	SELL	$40.9 - $45.1 $20,327 - $22,414	-497 Reduced 7.76%	5,904 $261,000
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $33,235 - $39,171	873 Added 15.79%	6,401 $273,000
Q3 2021 Oct 27, 2021	BUY	$41.23 - $45.88 $1,484 - $1,651	36 Added 0.66%	5,528 $240,000
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $7,253 - $8,317	-188 Reduced 3.31%	5,492 $235,000
Q1 2021 May 11, 2021	BUY	$35.27 - $39.67 $200,333 - $225,325	5,680 New	5,680 $219,000
Q4 2020 Jan 25, 2021	SELL	$33.15 - $41.97 $297,355 - $376,470	-8,970 Closed	0 $0
Q3 2020 Oct 22, 2020	BUY	$34.44 - $42.23 $5,544 - $6,799	161 Added 1.83%	8,970 $343,000
Q2 2020 Jul 31, 2020	SELL	$30.19 - $39.11 $46,039 - $59,642	-1,525 Reduced 14.76%	8,809 $309,000
Q1 2020 Apr 23, 2020	SELL	$25.83 - $45.71 $24,667 - $43,653	-955 Reduced 8.46%	10,334 $336,000
Q4 2019 Jan 22, 2020	BUY	$37.87 - $45.37 $3,938 - $4,718	104 Added 0.93%	11,289 $510,000
Q2 2019 Jul 25, 2019	BUY	$34.91 - $42.98 $68,912 - $84,842	1,974 Added 21.43%	11,185 $481,000
Q1 2019 May 09, 2019	BUY	$32.91 - $40.75 $4,870 - $6,031	148 Added 1.63%	9,211 $354,000
Q4 2018 Feb 04, 2019	BUY	$31.73 - $39.04 $87,511 - $107,672	2,758 Added 43.74%	9,063 $320,000
Q3 2018 Oct 30, 2018	BUY	$32.83 - $38.63 $5,778 - $6,798	176 Added 2.87%	6,305 $243,000
Q2 2018 Jul 19, 2018	BUY	$26.84 - $34.32 $164,502 - $210,347	6,129 New	6,129 $201,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $128B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Boston Scientific Corp Transaction History